Mémoires MASTER (GPE)

Permanent URI for this collection

Now showing 1 - 1 of 1

Quality control and comparative study of the formulation process of two drugs: Paralgan® 500 mg and Doliprane® 500 mg
(National Higher School of Technology and Engineering-Annaba, 2025) BENNAMANE Kenza; DHAOUI Nabila (Encadrant)
The aim of this work is a comprehensive study of a generic drug Paralgan®500mg produced by the Algerian pharmaceutical group SAIDAL DAR EL BEIDA.The study covers the various stages in the manufacture of this drug resulting in a pharmaceutical product complying with international standards, and the monitoring of various techniques for validating dosing methods. The results obtained from the physico-chemical analysis of the active ingredient (Paracetamol) comply with recommended standards. A quality comparison between this generic drug and its original drug (Doliprane®500mg) manufactured by the French pharmaceutical group SANOFI clearly shows their equivalence and compliance with international standards. Analysis of accelerated and long-term stability data under various storage conditions (temperature, humidity, light) will provide a better understanding of the factors influencing product durability, and enable us to optimize storage conditions.